2023
Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part II: cognitive-behavioral therapy
de Mathis M, Chacon P, Boavista R, de Oliveira M, de Barros P, Echevarria M, Ferrão Y, de Queiroz Vattimo E, Lopes A, Torres A, Diniz J, Fontenelle L, do Rosário M, Shavitt R, da Silva R, Miguel E, da Conceição Costa D. Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part II: cognitive-behavioral therapy. Brazilian Journal Of Psychiatry 2023, 45: 431-447. PMID: 37718254, PMCID: PMC10894635, DOI: 10.47626/1516-4446-2023-3081.Peer-Reviewed Original ResearchAdult obsessive-compulsive disorderObsessive-compulsive disorderTherapy treatmentHigh-quality scientific evidenceTreatment of adultsPrimary outcome measureHigh-quality evidenceAmerican Heart AssociationLevel of evidenceInternet-delivered CBTCognitive behavioral therapy treatmentBrazilian Research ConsortiumAdult patientsHeart AssociationClinical guidelinesTreatment recommendationsOutcome measuresAmerican CollegeSystematic reviewCBT interventionClinical interventionsCBT treatmentStudy designCBT protocolResponse prevention
2011
A Double-Blind, Randomized, Controlled Trial of Fluoxetine Plus Quetiapine or Clomipramine Versus Fluoxetine Plus Placebo for Obsessive-Compulsive Disorder
Diniz J, Shavitt R, Fossaluza V, Koran L, de Bragança Pereira C, Miguel E. A Double-Blind, Randomized, Controlled Trial of Fluoxetine Plus Quetiapine or Clomipramine Versus Fluoxetine Plus Placebo for Obsessive-Compulsive Disorder. Journal Of Clinical Psychopharmacology 2011, 31: 763-768. PMID: 22020357, DOI: 10.1097/jcp.0b013e3182367aee.Peer-Reviewed Original ResearchConceptsY-BOCS scoresFluoxetine groupTreatment regimenSelective serotonin reuptake inhibitorsPlacebo-controlled trialSevere adverse eventsSerotonin reuptake inhibitorsMain outcome measuresObsessive-compulsive disorder patientsCompulsive Scale scoresYale-Brown ObsessiveFluoxetine monotherapyAdverse eventsReuptake inhibitorsObsessive-compulsive disorderPrimary diagnosisOutcome measuresDisorder patientsScale scoreFluoxetineMental disordersQuetiapinePatientsStatistical ManualClomipramine